Reductions in Antibiotic Prescribing in Australia During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: National Prescribing Data

Clin Infect Dis. 2022 Aug 24;75(1):e1202-e1203. doi: 10.1093/cid/ciac277.

Authors

Jack Skeggs^{1

2}, Aleece MacPhail^{1

2}, Tony Korman^{1

2}, Ian Woolley^{1

2}, Jillian S Y Lau^{1

2}

Affiliations

¹ Monash Infectious Diseases, Monash Health, Clayton, Australia.
² Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Anti-Bacterial Agents / therapeutic use
COVID-19*
Humans
Inappropriate Prescribing
Pandemics
Practice Patterns, Physicians'
Respiratory Tract Infections* / epidemiology
SARS-CoV-2

Substances

Anti-Bacterial Agents